Conditions & Recovery · Cancer Health Magazine · September 3, 2026

FDA Approves New Oral Treatment for Non-Small-Cell Lung Cancer

The FDA approved sevabertinib for adults with HER2 mutations who have already undergone first-line treatment.

Originally published by Cancer Health Magazine. We curate and add context; they did the reporting.

Related learning